Economic evaluation and clinical trials: size matters
- 2 December 2000
- Vol. 321 (7273) , 1362-1363
- https://doi.org/10.1136/bmj.321.7273.1362
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: Clinical effectivenessBMJ, 2000
- Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: Cost effectivenessBMJ, 2000
- The Distribution of Health Care Costs and Their Statistical Analysis for Economic EvaluationJournal of Health Services Research & Policy, 1998
- Power and Sample Size Calculations for Stochastic Cost-Effectiveness AnalysisMedical Decision Making, 1998
- Treatment of Early-Stage Breast Cancer in the ElderlyMedical Decision Making, 1998
- Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?1996
- Statistics notes: Absence of evidence is not evidence of absenceBMJ, 1995
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978